Debora Pezzuolo

1.2k total citations · 1 hit paper
13 papers, 950 citations indexed

About

Debora Pezzuolo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Debora Pezzuolo has authored 13 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Debora Pezzuolo's work include Renal cell carcinoma treatment (6 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Debora Pezzuolo is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Debora Pezzuolo collaborates with scholars based in Italy, Brazil and Canada. Debora Pezzuolo's co-authors include Roberta Camisa, Andrea Ardizzoni, Antonino Musolino, Beatrice Bortesi, Marzia Capelletti, Tauro Maria Neri, Nadia Naldi, Alessandro Zerbini, Diletta Laccabue and Gabriele Missale and has published in prestigious journals such as Journal of Clinical Oncology, Lung Cancer and Cancer Immunology Immunotherapy.

In The Last Decade

Debora Pezzuolo

13 papers receiving 907 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer

2008 745 citations Antonino Musolino, Nadia Naldi et al. Journal of Clinical Oncology profile →

Peers

Debora Pezzuolo

ONCOL

RNMI

IMMUN

PRM

Irene Venturo United States

Beatrice Bortesi Italy

Abraham C.F. Leung United States

Éric Charpentier United States

Peter Ruf Germany

Aruna Mani United States

Ö. Türeci Germany

Mohini Rajasagi United States

France Blanchard France

Christina Krupka Germany

Irene Venturo United States

Debora Pezzuolo

525 ×0.9

ONCOL

243 ×0.5

RNMI

288 ×0.8

IMMUN

336 ×1.1

115 ×0.8

PRM

Citations per year, relative to Debora Pezzuolo Debora Pezzuolo (= 1×) peers Irene Venturo

Countries citing papers authored by Debora Pezzuolo

Since Specialization

Citations

This map shows the geographic impact of Debora Pezzuolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debora Pezzuolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debora Pezzuolo more than expected).

Fields of papers citing papers by Debora Pezzuolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debora Pezzuolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debora Pezzuolo. The network helps show where Debora Pezzuolo may publish in the future.

Co-authorship network of co-authors of Debora Pezzuolo

This figure shows the co-authorship network connecting the top 25 collaborators of Debora Pezzuolo. A scholar is included among the top collaborators of Debora Pezzuolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debora Pezzuolo. Debora Pezzuolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Buti, Sebastiano, Paola Bordi, Marcello Tiseo, et al.. (2015). Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients. Lung Cancer. 88(3). 319–324. 6 indexed citations

Passalacqua, Rodolfo, Caterina Caminiti, Sebastiano Buti, et al.. (2014). Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC). Journal of Immunotherapy. 37(9). 440–447. 59 indexed citations

Giovanardi, Filippo, et al.. (2013). Increased Mean Corpuscular Volume of Red Blood Cells in Patients Treated with Capecitabine for Advanced Breast and Colon Cancer. Chemotherapy. 59(5). 369–372. 4 indexed citations

Buti, Sebastiano, et al.. (2012). Changes in lymphocyte count induced by repeated cycles with low-dose interleukin-2 and interferon-α in 146 patients with renal cell carcinoma.. PubMed. 98(1). 45–52. 1 indexed citations

Buti, Sebastiano, et al.. (2012). Changes in Lymphocyte Count Induced by Repeated Cycles with Low-Dose Interleukin-2 and Interferon-α in 146 Patients with Renal Cell Carcinoma. Tumori Journal. 98(1). 45–52. 1 indexed citations

Pezzuolo, Debora, et al.. (2010). Low Dose Fractionated Cisplatin Plus Gemcitabine for Elderly Patients with Advanced Non Small Cell Lung Cancer: A Retrospective Analysis. Journal of Chemotherapy. 22(4). 275–279. 2 indexed citations

Passalacqua, Rodolfo, Carlo Buzio, Sebastiano Buti, et al.. (2009). Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer. Cancer Immunology Immunotherapy. 59(4). 553–561. 18 indexed citations

Mambrini, Andrea, et al.. (2009). Gemcitabine-capecitabine plus intra-arterial epirubicin-cisplatin in pretreated pancreatic cancer patients: a phase I study.. PubMed. 29(5). 1547–9. 4 indexed citations

Musolino, Antonino, Nadia Naldi, Beatrice Bortesi, et al.. (2008). Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer. Journal of Clinical Oncology. 26(11). 1789–1796. 745 indexed citations breakdown →

10.

Musolino, Antonino, Nadia Naldi, Beatrice Bortesi, et al.. (2008). In Reply. Journal of Clinical Oncology. 26(33). 5491–5492. 1 indexed citations

11.

Musolino, Antonino, Maria Angela Bella, Beatrice Bortesi, et al.. (2007). BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study. The Breast. 16(3). 280–292. 101 indexed citations

12.

Musolino, Antonino, et al.. (2006). Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/neu-positive metastatic breast cancer. Journal of Clinical Oncology. 24(18_suppl). 13090–13090. 5 indexed citations

13.

Passalacqua, Rodolfo, Carlo Buzio, R. Camisa, et al.. (2005). Phase III, randomized, multicentre trial of maintenance biotherapy with interleukin-2 (IL-2) and interferon-alpha (IFN) for metastatic renal cell cancer (RCC). Journal of Clinical Oncology. 23(16_suppl). 4605–4605. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact